INMB

INMB Operating Expenses

$20.09MTTM · USD

Period ending:

INMB FY Operating ExpensesUSD
INMB FY Operating Expenses2015-12-31: $48.87K2016-12-31: $227.49K2017-12-31: $981.48K2018-12-31: $12.44M2019-12-31: $7.76M2020-12-31: $12.24M2021-12-31: $29.33M2022-12-31: $26.33M2023-12-31: $29.90M2024-12-31: $42.65M2025-12-31: $30.92M$42.65M$0.00
2015-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

INMB operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 11 observations from Dec 31, 2015 to Dec 31, 2025.

Inmune Bio Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
30,919,000
42,649,000
29,896,000
26,325,000
29,334,000
12,239,000
7,756,001
12,440,000
981,480
227,491
48,868

Compare operating expenses

All INMB financial metrics · INMB stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.